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Purpose: To report a case of third, fourth, and six cranial nerve palsies with antiphospholipid syndrome 
(APS).
Methods: Medical records of a 16 year old female diagnosed with idiopathic intracranial hypertension (IIH) 
in primary APS were reviewed.
Results: A 16 year old female presented with headache and diplopia. Ocular examinations revealed marked 
bilateral disc edema. She was unable to depress, adduct, and abduct in left eye and had limited abduction 
in the right eye. Cerebrospinal fluid had a normal composition and a pressure of 400 mmH2O. Lupus 
anticoagulant and IgG anticardiolipin antibody were positive. There was no clinical evidence of other 
autoimmune disease. Brain magnetic resonance (MR) imaging, MR angiography, and conventional angiogram 
with venous phase were normal. She was diagnosed with bilateral sixth, and left third and fourth cranial 
nerve palsies secondary to idiopathic intracranial hypertension in primary APS. 
Conclusions: To our knowledge this is the first reported case of concurrent third, fourth, and sixth cranial 
nerve palsies in a patient with primary APS.  Korean Journal of Ophthalmology 20(1):76-78, 2006
Key Words: Antiphospholipid syndrome, Cranial nerve palsy 
Received: August 2, 2005    Accepted: January 6, 2006
Reprint requests to Sun Young Shin, MD. Department of Ophthal-
mology, Hanyang University Guri Hospital, Guri City, Gyunggi-do 
471-701, Korea. Tel: 82-31-560-2350, Fax: 82-31-564-9479, E-mail: 
eyeshin@hanyang.ac.kr 
＊This study was presented in part at the 92th annual meeting of the 
Korean Ophthalmological Society, 8-10, October, 2004. 
Antiphospholipid syndrome (APS) is an autoimmune 
disease in which patient are positive for lupus anticoagulant 
and anticardiolipin antibody with clinical symptoms of 
thrombosis, recurrent abortion, and thrombocytopenia. In the 
absence of clinical evidence of other autoimmune diseases 
the disease is referred to as primary APS. 
APS is associated with a wide range of neurological mani-
festations. Among these, idiopathic intracranial hypertension 
(IIH) may occur through mechanisms unrelated to major 
venous thrombosis. IIH may be associated with ocular 
motility deficits to our knowledge there is one case of third 
cranial nerve palsy presenting secondary to IIH in primary 
APS.
1 There are no reported cases of concurrent third, fourth, 
and sixth cranial nerve palsy presenting secondary to IIH as 
the initial ophthalmic manifestation of primary APS. 
Case Report
A 16 year old female presented with a headache that had 
lasted for one week and diplopia that started two days 
previously. She did not have a history of any ocular or 
systemic diseases and her family history was also 
unremarkable. Her height was 163 cm and her body weight 
was 49 kg, and she was not obese. Her blood pressure was 
120/80 mm Hg and a general medical examination revealed 
normal findings.
Ophthalmic examinations showed a visual acuity of 20/20 
in both eyes, a mid dilated pupil of the left eye, and marked 
bilateral disc edema with peripapillary hemorrhage. She was 
unable to depress, adduct, and abduct the left eye and had 
limited abduction of the right eye (Fig. 1). Visual field 
examination showed peripheral constriction and enlargement 
of the blind spot in both eyes. 
A complete neurological examination showed no abnormal 
findings except for limited ocular motion. Brain magnetic 
resonance (MR) imaging, MR angiography, and cerebral 
angiography with venous phase performed within 10 days of 
clinical onset were normal. Cerebrospinal fluid (CSF) 
examination revealed the following: pressure, 400 mm H2O; 
glucose, 61 mg/dl; protein, 17 mg/dl; red blood cells, 2 /mm
3; 
white blood cell, 1/mm
3; and culture, negative.
Laboratory analysis showed that the platelet count was 
19,000/mm
3. Prothrombin time was normal, but the activated 
partial thromboplastin time measured by the (aPTT)-mixing 
test was prolonged at 55s (normal range 25-39s). The 
erythrocyte sedimentation rate was elevated at 26 mm/h. SY  Shin,  et  al.  ANTIPHOSPHOLIPID  SYNDROME
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Fig. 1. Nine-gaze  eye  positions.  Range  of  motion  in  cardinal  position  demonstrates  impairment  of  downward,  lateral  and  medial  gaze  in 
t h e  l e f t  e y e ,  a n d  o f  l a t e r a l  g a z e  i n  t h e  r i g h t  e y e .
Urine analysis, an electrocardiograph and chest X-ray were 
normal. Values for C-reactive protein, fibrinogen, anti-
thrombin III, protein C, and protein S were all normal. 
Immunologic tests was positive for IgG anticardiolipin 
antibody (36.7 GPLunit/ml: range <10 GPLunit/ml) and for 
lupus anticoagulant. Antinuclear antibody, anti-dsDNA anti-
body, antineutrophil cytoplasmic antibodies, antiplatelet anti-
body, thyroid autoantibodies and rheumatoid factor were 
negative. The serologic test for syphilis was negative. There 
was no other abnormal findings such as butterfly lash, discoid 
lash, photophobia, oral ulcer, arthritis, renal dysfunction, 
pleuritis or pericarditis. There was no clinical evidence of 
other autoimmune disease.
Six days later, the patient complained of central scotoma 
of the right eye and the visual acuity of the right eye had 
decreased to 40/200. Fundus examination of the right eye 
revealed new preretinal and subhyaloid hemorrhage. No 
evidence of retinal vascular occlusion was present in fluores-
cein angiographies performed at this time and two months 
later. No change was observed in the ocular motion exami-
nation. At this time, the platelet count was 20,000/mm
3.
With an initial diagnosis of intracranial hypertension (IH), 
the platelet was treated with repeated lumbar puncture, 
acetazolamide, and diuretics. Since the CSF pressure did not 
decrease aspirin and steroid therapy was started and the CSF 
pressure was normalized after 28 days. Thirty days later, 
when the preretinal and subhyaloid hemorrhage of the right 
eye had decreased, heparin was administered and subse-
quently replaced with warfarin to maintain an international 
normalized ratio (INR) of 1.5-2.0. 
A follow-up examination after two months revealed the 
disappearance of retinal hemorrhage in the right eye, visual 
acuity of 20/20 in both eyes, and normal ocular movement. 
Lupus anticoagulant and IgG anticardiolipin antibody 
remained positive. 
Discussion
Based on the clinical and laboratory findings, the patient 
was diagnosed with bilateral sixth, and left third and fourth 
cranial nerve palsies secondary to IIH in primary APS. 
Sixth cranial nerve palsy is known to occur in 10 to 40 
% of patients in most series of IIH,
2-4 and third or fourth 
nerve palsy has been described occasionally.
5,6 However, 
concurrent third, fourth, and sixth nerve palsies in one patient 
has not been reported previously. In addition previous reports 
provided no details regarding the incomitancy of the ocular 
motor deviation in various gaze positions. Other conditions 
associated with third cranial nerve palsy include diabetes 
mellitus, trauma, syphilis, aneurysm, tumor, or sinus infection; 
none of these was found in our patient.
The prevalence of IIH has not yet been reported for 
patients with primary APS although several cases have been 
described.
7,8 The prevalence of anticardiolipin antibodies in 
patients with IIH was reported variously as 8.1%, 31% or 
43%.
8-10 However, the two highest results include patients 
with other risk factors for IIH and additional prothrombotic 
risk factors and are therefore considered to overestimate the 
prevalence w ith respect to A PS. It is also im portant to take 
into account the fact that it may be possible to have 
circulating antiphospholipid antibodies without an increased 
risk for thromboembolism, and the prevalence of IIH may 
therefore be lower than predicted. 
The term "idiopathic" requires the exclusion of intracranial 
venous sinus thrombosis. Our patient did not have overt sinus 
thrombosis although she may have partial dural sinus 
obstruction (venous sinus thrombosis involving the deep 
sinuses) that was missed by MR imaging or angiography. It Korean  J  Ophthalmol  Vol.20,  No.1,  2006
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is possible that non-occlusive thrombus lining the dural 
vessles could impede CSF absorption; however, cerebral 
vascular imaging was performed soon after the onset of 
symptoms while CSF pressure was still high and she 
recovered completely under therapy designed to lower the 
CSF pressure without anticoagulation. There is also a 
possibility that increased blood viscosity induced by 
anticardiolipin antibody without actual thrombosis may cause 
IH.
11
Preretinal and subhyaloid hemorrhage of the right eye was 
considered to be the result of papilledema rather than a 
venous thrombus caused by by hypercoagulation or throm-
bocytopenia, as the hemorrhage was located near the disc and 
there was no evidence of retinal vascular occlusion present 
in fluorescein angiographies performed at this time and two 
months later. It is likely that an intraretinal hemorrhage 
caused by papilledema resulted in detachment of the internal 
limiting membrane, leading to subhyaloid hemorrhage. 
This report describes the unusual presentation of a young 
female patient with bilateral sixth cranial nerve palsies, and 
left third and fourth cranial nerve palsies secondary to IIH 
with primary APS. Concurrent third, fourth and sixth cranial 
nerve palsies are a neurological complication that may be the 
initial ophthalmic manifestation of primary APS. 
References
1. Champion BL, Choy F, Schrieber L, et al. Isolated fascicular 
oculomoter nerve palsy as the initial presentation of the 
antiphospholipid syndrome. J Clin Neurosci 2002;9:691-4.
2. Johnston I, Paterson A. Benign intracranial hypertension. 
Brain 1974;97:289-312.
3. Weisberg LA. Benign intracranial hypertension. Medicine 
(Baltimore) 1975;54:197-207.
4. Boddie HG, Banna M, Bradley WG. "Benign" intracranial 
hypertension. A survey of the clinical and radiological 
features, and long-term prognosis. Brain 1974;97:313-26.
5. McCammon A, Kaufman HH, Sears ES. Transient oculo-
motor paralysis in pseudotumor cerebri. Neurology 1981;31: 
182-4.
6. Patton N, Beatty S, Lloyd IC. Bilateral sixth and fourth 
cranial nerve palsies in idiopathic intracranial hypertension. 
J R Soc Med 2000;93:80-1.
7. Orefice G, De Joanna G, Coppola M, et al. Benign intra-
cranial hypertension: a non-thrombotic complication of the 
primary APS?. Lupus 1995;4:324-6.
8. Falcini F, Taccetti G, Trapani S, et al. Primary APS: a 
report of two pediatric cases. J Rheumatol 1991:18:1085-7.
9. Kesler A, Ellis MH, Reshef T, et al. Idiopathic Intracranial 
hypertension and anticardiolipin antibodies. J Neurol 
Neurosurg Pscychiatry 2000;68:379-80.
10. Sussman J, Leach M, Greaves M, et al. Potentially proth-
rombotic abnormalities of coagulation in benign intacranial 
hypertension. J Neurol Neurosurg Pscychiatry 1997;62:229- 
33.
11. Leker RR, Steiner I. Anticardiolipin Antibodies are frequently 
present in patients with idiopathic intracranial hypertension. 
Arch Neurol 1998;55:817-20.